ARCHIVES

NIH scientists defend industry ties while officials vow conflicts review; three investigations planned.

This article is from The Cancer Letter archive.

Vol. 30 No. 04 | January 23, 2004

Download PDF Visit The Full Archive

Related Articles

Breast Cancer Patients Track Symptoms With Digital Device

September 25, 2009

Six Years into The Drug Shortage, And The Causes Are Still a Mystery

October 14, 2011

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

Ibrutinib Demonstrates Responses In Large B-Cell Lymphomas

April 27, 2012

Annual Report Key Element In Prevention Drive, Maquire Insists

February 2, 1979

Mass. Requires Coverage of Routine Patient Care In Clinical Trials

September 6, 2002